Stock comparison
Elevance Health
Eli Lilly
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ELV
Elevance Health
Market cap
$85.71B
Sector
Healthcare
LLY
Eli Lilly
Market cap
$1T
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ELV | LLY | Winner |
|---|---|---|---|
| Warren Buffett | 35D | 72B | LLY |
| Benjamin Graham | 52C | 86A | LLY |
| Philip Fisher | 17F | 86A | LLY |
| Peter Lynch | 21F | 74B | LLY |
| Joel Greenblatt | 28F | 78C | LLY |
| Charlie Munger | 24F | 85A | LLY |
| Terry Smith | 19F | 77C | LLY |
Side-by-side metrics
| Metric | ELV | LLY |
|---|---|---|
| Market cap | $85.71B | $1T |
| P/E (TTM) | 16.5x | 36.6x |
| EV/EBIT | 13.2x | 34.1x |
| ROIC (TTM) | 7.91% | 32.06% |
| Gross margin | 23.16% | 83.51% |
| Net margin | 2.62% | 34.98% |
| Revenue CAGR 5y | 9.47% | 23.17% |
| EPS CAGR 5y | -0.07% | 40.81% |
| Debt / Equity | 0.7x | 1.4x |
| Dividend yield | 1.74% | 0.62% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ELV leads on
- Dividend yield1.74%vs 0.62%+64%
- EV/EBIT13.2xvs 34.1x+61%
- P/E (TTM)16.5xvs 36.6x+55%
- Debt / Equity0.7xvs 1.4x+48%
LLY leads on
- EPS CAGR 5y40.81%vs -0.07%+100%
- Net margin34.98%vs 2.62%+93%
- Market cap$1Tvs $85.71B+91%
- ROIC (TTM)32.06%vs 7.91%+75%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.